Skip to main content

Vident Advisory, LLC

Source: SEC Form 13F · as of Mar 2026

Vident Advisory, LLC holds 42 biotech & pharma companies tracked by BioSniper, totaling $81.1M in value as of Mar 2026 (SEC Form 13F).

Companies held

42

Total value held

$81.1M

BioSniper AIPage context preserved

Prepared research question

What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
GILDGILEAD SCIENCES, INC.162,497$22.6M
SNYSanofi351,952$17.0M
EXELEXELIXIS, INC.148,830$6.4M
JAZZJazz Pharmaceuticals plc23,032$4.4M
RDYDR REDDYS LABORATORIES LTD217,581$3.0M
REGNREGENERON PHARMACEUTICALS, INC.3,449$2.7M
ALNYALNYLAM PHARMACEUTICALS, INC.6,457$2.1M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)36,983$2.0M
INSMINSMED Inc9,808$1.6M
TEVATeva Pharmaceutical Industries Limited49,744$1.5M
GMABGenmab A/S48,379$1.3M
CYTKCYTOKINETICS INC17,069$1.1M
RVMDREVOLUTION MEDICINES, INC.11,277$1.1M
ADMAADMA BIOLOGICS, INC.120,835$1.1M
INCYIncyte Corp.11,550$1.1M
ARGXARGENX SE1,322$965K
LGNDLigand Pharmaceuticals Incorporated4,645$927K
RGCRegencell Bioscience Holdings Ltd29,588$752K
ONCBeOne Medicines Ltd.2,486$738K
ROIVRoivant Sciences Ltd.26,088$723K
IONSIONIS PHARMACEUTICALS INC9,489$713K
INVAInnoviva, Inc.28,388$661K
APLSApellis Pharmaceuticals, Inc.15,079$607K
PCVXVaxcyte, Inc.9,504$552K
GRFSGrifols S.A.64,309$516K
PTGXProtagonist Therapeutics, Inc4,481$472K
MRNAModerna, Inc.7,788$396K
ANIPANI PHARMACEUTICALS INC4,935$380K
TGTXTG THERAPEUTICS, INC.11,219$373K
BMRNBIOMARIN PHARMACEUTICAL INC6,506$368K
AXSMAxsome Therapeutics, Inc.2,099$355K
MLTXMoonLake Immunotherapeutics18,208$339K
NUVLNuvalent, Inc.3,266$335K
APGEApogee Therapeutics, Inc.3,385$285K
HCMHUTCHMED (China) Limited17,726$265K
KNSAKiniksa Pharmaceuticals International, plc5,107$246K
VKTXViking Therapeutics, Inc.7,509$244K
IMVTImmunovant, Inc.9,011$224K
BBIOBridgeBio Pharma, Inc.2,974$221K
ARWRARROWHEAD PHARMACEUTICALS, INC.3,479$218K
TLXTelix Pharmaceuticals Limited16,653$159K
RXRXRECURSION PHARMACEUTICALS, INC.14,049$43K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.